A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

By Melisko Michelle  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry for Lymph Node Metastases in Endometrial Carcinoma

By Iwai K.   Fukuda K.   Hachisuga T.   Mori M.   Uchiyama M.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 351-359

Elsevier

Access to resources Recommend Favorite

Significance of Pathologic Patterns of Pelvic Lymph Node Metastases in Endometrial Cancer

By Mariani A.   Webb M.J.   Rao S.K.   Lesnick T.G.   Podratz K.C.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

By Jonsdottir Kristin   Zhang Hui   Jhagroe Darshni   Skaland Ivar   Slewa Aida   Björkblom Benny   Coffey Eleanor   Gudlaugsson Einar   Smaaland Rune   Janssen Emiel   Baak Jan  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Postoperative Vaginal Vault Brachytherapy for Node-Negative Stage II (Occult) Endometrial Carcinoma

By Ng T.Y.   Nicklin J.L.   Perrin L.C.   Cheuk R.   Crandon A.J.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 193-195

Elsevier

Access to resources Recommend Favorite